证券代码：002569 证券简称：*ST 步森 公告编号：2025-065 浙江步森服饰股份有限公司 关于股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别风险提示： 1、公司 2024 年度审计机构北京国府嘉盈会计师事务所（特殊普通合伙）对公 司出具了 2024 年度审计报告，公司触及《深圳证券交易所股票上市规则》第 9.3.1 条（一）的规定：上市公司出现"最近一个会计年度经审计的利润总额、净利润、 扣除非经常性损益后的净利润三者孰低为负值，且扣除后的营业收入低于 3 亿元" 的情形，根据《深圳证券交易所股票上市规则》的相关规定，公司股票交易已被实 施"退市风险警示"。同时，因公司存在"公司最近三个会计年度扣除非经常性损 益前后净利润孰低者均为负值，且最近一年审计报告显示公司持续经营能力存在不 确定性"的情形，根据《深圳证券交易所股票上市规则》第 9.8.1 第（七）条的相 关规定，公司股票将继续实施"其他风险警示"。若 2025 年经审计后的相关指标 触及《深圳证券交易所股票上市规则》第 9.3.12 条规定的相关情形，公司股票将 ...

Core Insights - *ST Bosen (002569.SZ) reported a revenue of 37.0383 million yuan for Q3 2025, representing a year-on-year increase of 14.86% [1] - The net profit for Q3 was 4.7954 million yuan, showing a significant year-on-year growth of 172.09% [1] - For the first three quarters, the company achieved a total revenue of 88.9898 million yuan, which is a year-on-year decrease of 12.49% [1] - The company reported a net loss of 5.6648 million yuan for the first three quarters [1]

第七届监事会第三次会议决议公告 证券代码：002569 证券简称：*ST 步森 公告编号：2025-063 浙江步森服饰股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 （2）2025 年第三季度报告的内容和格式符合中国证监会和深圳证券交易所的 各项规定，所包含的信息能从各个方面真实、准确、完整地反映出公司 2025 年三 季度的经营管理和财务状况； （3）2025 年第三季度报告所披露信息不存在任何虚假记载、误导性陈述或者 重大遗漏，在提出本意见前，未发现参与公司 2025 年第三季度报告编制和审议的 人员有违反保密规定的行为。 浙江步森服饰股份有限公司（以下简称"公司"）第七届监事会第三次会议于 2025 年 10 月 23 日在公司会议室以现场结合通讯方式召开，会议通知于 2025 年 10 月 20 日以电话通知、微信通知、电子邮件等方式送达全体监事。本次会议应出席监 事 3 名，实际出席监事 3 名。本次会议的召集、召开符合《中华人民共和国公司法》 等有关法律、行政法规、部门规章、规范性文件和《公司章程》《公司监事 ...

证券代码：002569 证券简称：*ST 步森 公告编号：2025-062 浙江步森服饰股份有限公司 1、《关于公司<2025 年第三季度报告>的议案》 公司《2025 年第三季度报告》符合法律、行政法规、中国证监会和深圳证券交 易所的相关规定，内容真实、准确、完整，不存在任何虚假记载、误导性陈述或者 重大遗漏。 表决结果：9 票同意，0 票反对，0 票弃权。 具体内容详见与本公告同日披露在《证券日报》《证券时报》《中国证券报》 及巨潮资讯网（http://www.cninfo.com.cn）上的公告《2025 年第三季度报告》。 三、备查文件 第七届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江步森服饰股份有限公司（以下简称"公司"）第七届董事会第四次会议于 2025 年 10 月 23 日以通讯方式召开，会议通知于 2025 年 10 月 20 日以电话通知、 微信通知等方式送达全体董事。本次会议应出席董事 9 名，实际出席董事 9 名。本 次会议的召集、召开符合《中华人民共和国公司法》等有关法律、行 ...

Financial Performance - The company's revenue for Q3 2025 was ¥37,038,340.96, representing a 14.86% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥4,795,426.49, a significant increase of 172.09% year-on-year[5] - The basic earnings per share rose to ¥0.0333, reflecting an increase of 183.25% compared to the previous year[5] - The company reported a 58.68% increase in total profit compared to the previous year, driven by improved operating profit[9] - The net profit attributable to the parent company's shareholders increased by 56.15% year-on-year, primarily due to the increase in total profit[10] - Net loss for the period was ¥5,905,271.45, compared to a net loss of ¥14,314,772.13 in the previous period, indicating an improvement of approximately 58.8%[21] - The company reported an investment loss of ¥935,401.72, an improvement from a loss of ¥1,860,792.70 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥198,253,838.55, up 4.76% from the end of the previous year[5] - The company's total assets increased to ¥198,253,838.55 from ¥189,252,899.14, reflecting a growth of about 4.3%[18] - Total liabilities rose to ¥170,906,922.10 from ¥156,034,068.72, an increase of approximately 9.6%[18] - The equity attributable to shareholders decreased to ¥28,851,441.08 from ¥34,482,896.96, a decline of about 16.5%[18] Cash Flow - The company's cash flow from operating activities showed a net decrease of 51.81%, amounting to -¥22,720,699.17 year-to-date[5] - Operating cash inflow for the current period was ¥86,815,448.22, a decrease of 35% from ¥133,623,387.89 in the previous period[23] - Net cash outflow from operating activities was ¥22,720,699.17, compared to a net outflow of ¥14,966,091.28 in the previous period[23] - Cash outflow for purchasing goods and services was ¥54,448,328.01, down from ¥72,073,994.16, reflecting a 24.5% reduction[23] - Cash inflow from financing activities was ¥21,500,000.00, with a net cash inflow of ¥20,462,000.00 after accounting for cash outflows[24] - The ending balance of cash and cash equivalents was ¥2,795,498.87, compared to ¥2,495,807.03 in the previous period, indicating a slight increase[24] - Cash outflow related to financing activities was ¥1,038,000.00, significantly lower than ¥11,418,000.00 in the previous period, marking a decrease of approximately 91%[24] - The company experienced a net decrease in cash and cash equivalents of ¥2,220,820.99, compared to a larger decrease of ¥26,560,514.54 in the previous period[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 4,807[12] - The largest shareholder, Baoji Fangwei Tongchuang Enterprise Management Partnership, holds 14.81% of shares, totaling 21,333,760 shares[12] Research and Development - Research and development expenses decreased by 100.00% compared to the same period last year, indicating a reduction in R&D investment[9] - Research and development expenses were significantly reduced to ¥0.00 from ¥1,430,471.12, indicating a strategic shift in investment[20] Corporate Actions - The company plans to terminate the 2020 restricted stock incentive plan and is in the process of repurchasing related stocks[14] - The company will actively promote the repurchase of restricted stocks based on its funding situation[14] - The company is closely monitoring the progress of the repurchase and will comply with relevant disclosure obligations[14] Accounting and Auditing - The company has not yet audited its third-quarter financial report[25] - The company plans to implement new accounting standards starting from 2025[25]

暨关联交易事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、关联交易概述 证券代码：002569 证券简称：*ST 步森 公告编号：2025-061 浙江步森服饰股份有限公司 关于向宝鸡方维同创企业管理合伙企业(有限合伙)借款 特此公告。 浙江步森服饰股份有限公司董事会 2025 年 10 月 10 日 浙江步森服饰股份有限公司（以下简称"公司"）于 2025 年 8 月 4 日召开 2025 年 第七届董事会第二次会议，审议通过了《关于拟向宝鸡方维同创企业管理合伙企业(有 限合伙)借款暨关联交易的议案》。公司根据融资状况及资金需求向宝鸡方维同创企业 管理合伙企业(有限合伙)（以下简称"方维同创"）借款人民币 2,000 万元，借款有效 期为 2 个月。借款利率参照银行等金融机构同期贷款利率水平及出借人实际融资成本， 借款利率（年利率）定为 5.00 %。具体内容详见披露于《证券日报》《证券时报》《中 国证券报》及巨潮资讯网（http://www.cninfo.com.cn）上的公告《关于拟向宝鸡方维 同创企业管理合伙企业(有限合伙)借款暨关 ...

证券代码：002569 证券简称：*ST 步森 公告编号：2025-060 浙江步森服饰股份有限公司 关于筹划重大资产重组的进展公告 2、经初步测算，本次交易预计构成《上市公司重大资产重组管理办法》规定的重 大资产重组，本次交易不涉及公司发行股份，不构成重组上市，亦不会导致公司控股 股东和实际控制人发生变更。 3、本次交易尚处于筹划阶段，交易方案、交易价格等核心要素仍需进一步论证和 协商，并需按照相关法律、法规及公司章程的规定履行必要的内外部决策和审批程序， 存在未能通过该等决策、审批程序的风险。 4、本次交易相关事项尚存在重大不确定性，可能出现因外部环境变化导致交易条 件发生变化或公司与交易对方未能就交易方案达成一致等情形，进而导致交易终止的 情况。敬请广大投资者注意投资风险。 一、本次交易概述 浙江步森服饰股份有限公司（以下简称"公司"、"上市公司"或"步森股份"） 为优化资产结构，改善现金流状况，集中资源进一步聚焦主业，筹划拟以现金方式向 南通二纺机有限公司（以下简称"南通二纺机"）出售陕西步森服饰智造有限公司（以 下简称"陕西步森"）35%的股权。本次交易完成后，公司将不再持有陕西步森任何 股权。 经 ...

证券代码：002569 证券简称：*ST 步森 公告编号：2025-059 | 户名 | 开户行 | | 银行账号 | 账户性质 | 实际冻结金额 | | --- | --- | --- | --- | --- | --- | | | | | | | (单位：元) | | 浙江步森服饰 | 中国建设银行股份有限公司 诸暨枫桥支行 | | 3300165635905300**** | 基本户 | 297,083.00 | | 股份有限公司 | 中国建设银行股份有限公司 诸暨支行 | | 3305016563350000**** | 一般户 | 2,183.75 | | 杭州创展步森 服饰有限公司 | 中信银行杭州分行营业部 | | 733101018220012**** | 基本户 | 2,000.00 | | | 合 | 计 | | | 301,266.75 | 二、账户解除冻结原因 公司初步判断本次银行账户解除冻结事项系公司与诸暨市步森服饰有限公司房 屋租赁合同纠纷处理完成所致。 三、本次冻结事项对公司的影响 1、截至目前，公司（含孙公司）合计冻结金额为 301,266.75 元，占公司 2024 年度经审 ...

Group 1: Mergers and Acquisitions Overview - During the period from September 5 to September 11, 2025, two listed companies announced new mergers and acquisitions, namely *ST Bosen and Xiangrikui, involving two merger and acquisition events in the textile and apparel, and pharmaceutical industries [1][7]. Group 2: *ST Bosen - *ST Bosen is focused on men's apparel design, production, and sales, with its main brand "Bosen Men's Wear" promoting the concept of "comfortable business men's clothing" [2][7]. - The company plans to sell 35% of its stake in Shaanxi Bosen Apparel Intelligent Manufacturing Co., Ltd. to Nantong Erfangji Co., Ltd. in cash, aiming to optimize its asset structure and improve cash flow [2][7]. - Shaanxi Bosen was established on April 13, 2021, with a registered capital of 200 million yuan, and is primarily engaged in clothing manufacturing and sales [2][7]. Group 3: Xiangrikui - Xiangrikui is engaged in the research, production, and sales of pharmaceuticals, focusing on anti-infection, cardiovascular, and digestive system drugs, with a complete integrated industrial chain [3][8]. - The company plans to acquire a controlling stake in Zhangzhou Xipu Material Technology Co., Ltd. and 40% of Zhejiang Beid Pharmaceutical Co., Ltd. through issuing shares and/or cash payments, while also raising matching funds [3][8]. - Major products include clarithromycin raw materials and tablets, widely used for treating infectious diseases, hypertension, and digestive system diseases [3][8].

Core Viewpoint - *ST Bosen (002569) announced a significant asset restructuring plan involving the sale of 35% equity in Shaanxi Bosen Apparel Intelligent Manufacturing Co., Ltd. to Nantong Erfang Machine Co., Ltd. This transaction will result in the company no longer holding any equity in Shaanxi Bosen [1][1][1] Group 1 - On September 8, *ST Bosen's stock opened with a limit-up, reaching a price of 9.65 yuan per share [1][1][1] - The announcement regarding the equity sale was made on the evening of September 7, indicating a strategic move by the company [1][1][1] - The transaction is expected to be classified as a major asset restructuring according to the regulations of the "Management Measures for Major Asset Restructuring of Listed Companies" [1][1][1] Group 2 - The transaction will not involve the issuance of new shares by *ST Bosen, nor will it lead to a change in the company's control [1][1][1] - After the completion of the transaction, *ST Bosen will completely divest from Shaanxi Bosen, indicating a shift in its investment strategy [1][1][1]